The chemokine CCL17 was significantly highly expressed in the ERS high-risk subgroup, whereas CCL28, CXCL12, and CXCL16 were expressed significantly less (Fig. 9B). The gene discussed is CXCL16; the disease is amelogenesis imperfecta type 1G.